CSIMarket Company Name, Ticker, Customers, else..
 

Fresh Tracks Therapeutics Inc   (FRTX)

Fresh Tracks Therapeutics Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

FRTX Sales vs. its Competitors Q4 2023


Comparing the current results to its competitors, Fresh Tracks Therapeutics Inc reported Revenue decrease in the 4 quarter 2023 year on year by 0 %, despite the revenue increase by the most of its competitors of 22.57 %, recorded in the same quarter.

• List of FRTX Competitors





Revenue Growth Comparisons




Net Income Comparison

Fresh Tracks Therapeutics Inc , slower than the average decrease reported by the company's competitors of -87.21 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -87.21 %

<<  FRTX Stock Performance Comparisons





*Market share is calculated based on total revenue.





Publicly Traded Peers of Fresh Tracks Therapeutics Inc




Adaptimmune Therapeutics Plc
Share Performance



-92.55%
One Year
Adaptimmune Therapeutics Plc
Profile

Adaptimmune Therapeutics Plc is a biopharmaceutical company that focuses on developing and commercializing innovative cancer immunotherapy products. Their business model revolves around leveraging their T-cell receptor platform to engineer and develop targeted immunotherapies for patients with various types of cancer.

More about Adaptimmune Therapeutics Plc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 14.498 mill. $ 65.085 mill. $ -169.756 mill.


Iteos Therapeutics Inc
Share Performance



-39.80%
One Year
Iteos Therapeutics Inc
Profile

Iteos Therapeutics Inc is a company that focuses on developing innovative immunotherapies to treat cancer by targeting the tumor microenvironment.

More about Iteos Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 442.180 mill. $ - mill. $ -202.412 mill.


Relay Therapeutics Inc
Share Performance



-3.79%
30 Days
Relay Therapeutics Inc
Profile

Relay Therapeutics Inc is a biotechnology company focused on developing targeted therapies for diseases by leveraging insights from protein motion. Their business model involves utilizing computational simulations and algorithms to discover and design small molecule therapies that can effectively target specific proteins involved in various diseases.

More about Relay Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 3,858.197 mill. $ 10.349 mill. $ -286.037 mill.


Seagen Inc
Share Performance



+73.22%
One Year
Seagen Inc
Profile

Seagen Inc is a biotechnology company that focuses on developing and commercializing innovative cancer therapeutics. Their business model revolves around research and development of targeted antibody-based drugs, specifically using their proprietary antibody-drug conjugate (ADC) technology. Seagen Inc also seeks strategic collaborations and partnerships with other pharmaceutical companies to enhance their product pipeline and expand their market reach.

More about Seagen Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 43,034.000 mill. $ 2,300.351 mill. $ -750.225 mill.


Surface Oncology Inc
Share Performance



0.00%
Over The Past 5 Days
Surface Oncology Inc
Profile

Surface Oncology Inc is a biotechnology company focused on developing innovative immunotherapies to treat cancer. They employ a research-driven approach to identify and target novel immune checkpoints and design therapeutic antibodies to activate the immune system against tumors. Their business model revolves around conducting preclinical and clinical research, collaborating with strategic partners, and licensing or commercializing their products to bring new treatment options to patients.

More about Surface Oncology Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 64.968 mill. $ - mill. $ -92.505 mill.

22 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Fresh Tracks Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Fresh Tracks Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.